PDF Cover

Mannan Oligosaccharide Market

The market for Mannan Oligosaccharide was estimated at $1.5 billion in 2024; it is anticipated to increase to $2.3 billion by 2030, with projections indicating growth to around $3.5 billion by 2035.

Report ID:DS1903003
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Food & Beverage
Animal Feeds
Mannan Oligosaccharide
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Mannan Oligosaccharide Market Outlook

Revenue, 2024

$1.5B

Forecast, 2034

$3.2B

CAGR, 2025 - 2034

8.2%

The Mannan Oligosaccharide (MOS) industry revenue is expected to be around $1.6 billion in 2025 and expected to showcase growth with 8.2% CAGR between 2025 and 2034. Building on this trajectory, the Mannan Oligosaccharide market is consolidating its position as a critical MOS prebiotic and animal feed additive, driven by the global shift toward antibiotic-free production, heightened focus on gut health enhancer solutions, and stricter food safety standards that favor functional, science-backed ingredients; Powder Grade currently leads the competitive landscape with $1.21 billion in sales in 2024, reflecting its versatility, cost-efficiency, and ease of incorporation into high-volume animal feed and food & beverage processing chains, as manufacturers prioritize reliable, immune-modulating inputs that integrate seamlessly into existing formulations and processing lines.

Mannan Oligosaccharide, a yeast cell wall-derived oligosaccharide, is valued for its ability to support gut integrity, bind pathogenic bacteria, and enhance immune modulation, making it a preferred functional food ingredient and performance booster across Animal Nutrition & Feed and Food & Beverage Processing, which together command 86.0% of total application demand; its broad utility spans poultry feed, aquaculture feed, pet nutrition, and human dietary supplements, while recent trends such as accelerated adoption of clean label formulations, demand for natural prebiotic alternatives, and ongoing product innovation in Powder Grade formats are reinforcing its strategic role in efficiency-focused, health-oriented nutrition strategies across global value chains

Mannan Oligosaccharide market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Mannan Oligosaccharide Market Outlook

Market Key Insights

  • The Mannan Oligosaccharide market is projected to grow from $1.5 billion in 2024 to $3.2 billion in 2034. This represents a CAGR of 8.2%, reflecting rising demand across Functional Feed Additives, Pharmaceutical Use, and Wastewater Treatment.

  • The market exhibits an oligopolistic structure with only 7 prominent players, with Alltech Inc. and DuPont Nutrition & Health commanding the largest shares.

  • U.S. and China are the top markets within the Mannan Oligosaccharide market and are expected to observe the growth CAGR of 6.0% to 8.6% between 2024 and 2030.

  • Emerging markets including Indonesia, Russia and India are expected to observe highest growth with CAGR ranging between 7.9% to 10.3%.

  • Slow adoption of Increasing Demand in Animal Feed Industry transition within key players in Mannan Oligosaccharide market is creating a revenue window for adjacent and alternate markets like Fructooligosaccharides (FOS) and Galactooligosaccharides (GOS) to improve its use-case penetration in Animal Nutrition & Feed and Food & Beverage Processing applications and expected to capture $110 million revenue from existing Mannan Oligosaccharide market.

  • The Mannan Oligosaccharide market is set to add $1.8 billion between 2024 and 2034, with manufacturer targeting Food & Beverage Processing & Dietary Supplements Application projected to gain a larger market share.

  • With

    rising demand in animal feed industry, and

    Increasing Application in Human Nutritional Supplements, Mannan Oligosaccharide market to expand 120% between 2024 and 2034.

mannan oligosaccharide market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Mannan Oligosaccharide - Country Share Analysis

Opportunities in the Mannan Oligosaccharide

Food-grade Mannan Oligosaccharide is also emerging as a high-value prebiotic fiber for North American functional foods and nutraceuticals. With the global food segment already near $1.21 billion in 2024 and projected to reach $1.89 billion by 2030 at 7.8% CAGR, penetration into everyday bakery, plant-based dairy, and wellness beverages remains limited. Untapped opportunity lies in senior digestive health, women’s wellness, and targeted gut health formulations, where clean-label, low-dose MOS can differentiate brands and command premium pricing across retail and online channels.

Growth Opportunities in North America and Asia-Pacific

In North America, Animal Nutrition & Feed is the dominant application for Mannan Oligosaccharide, with MOS prebiotics embedded in high-value poultry feed, ruminant rations, and performance-focused pet nutrition formulas, driving consistent demand for functional animal feed additives that support gut health and antibiotic reduction strategies. Top regional opportunities lie in premium, label-friendly formulations, integration of Mannan Oligosaccharide into customized micro-premixes, and expansion into veterinary-recommended companion animal products, where willingness to pay for scientifically substantiated benefits is high. Competition is characterized by technically strong feed additive suppliers, vertically integrated livestock producers with in-house formulation capabilities, and specialized distributors promoting differentiated prebiotic blends, making evidence-based positioning, on-farm trial data, and close collaboration with nutritionists essential. Regulatory support for reduced antibiotic use, retailer pressure for welfare and sustainability claims, and rising consumer expectations for safe, high-quality animal protein act as primary drivers, reinforcing Mannan Oligosaccharide’s role as a strategic functional ingredient across intensive livestock systems and advanced pet food categories.
In Asia-Pacific, Animal Nutrition & Feed also represents the most influential application for Mannan Oligosaccharide, with rapid growth in poultry feed and swine diets where cost-effective MOS prebiotics help improve feed efficiency, resilience against enteric challenges, and overall gut health under high-density production conditions. Top opportunities stem from localizing production and formulation to meet price-sensitive markets, partnering with regional feed millers for co-branded performance programs, and tailoring Mannan Oligosaccharide inclusion strategies to species- and life-stage-specific needs, including aquaculture and emerging pet nutrition segments. Competitive intensity is increasing as multinational feed additive providers, domestic premix formulators, and generic suppliers all target similar customers, making technical service, field demonstration trials, and clear differentiation on quality, consistency, and bioactivity critical for share gains. Key regional drivers include structural expansion of commercial livestock operations, government-led initiatives to curb antimicrobial use, rising disposable income supporting demand for higher-quality animal protein, and a gradual shift toward functional ingredients that support animal welfare and production efficiency, positioning Mannan Oligosaccharide as a cornerstone prebiotic fiber within modern feed programs.

Market Dynamics and Supply Chain

01

Driver: Rising demand for gut health improvement in livestock coupled with growing aquaculture industry

The global mannan oligosaccharide market is also strongly driven by increasing awareness of gut health in livestock and the rapid expansion of the aquaculture sector. In livestock, MOS is also used as a prebiotic feed additive to enhance nutrient absorption, improve intestinal microflora balance, and reduce pathogenic bacteria, thereby boosting growth performance and feed efficiency. Meanwhile, the aquaculture industry is also adopting MOS to support fish and shrimp immunity, reduce disease outbreaks, and improve survival rates. Both trends are also fueled by the push for antibiotic-free production and sustainable animal husbandry practices. Companies such as Alltech, Cargill, and ADM are also innovating MOS formulations specifically tailored to different species, leveraging advancements in yeast extraction technologies and high-purity processing to enhance functional efficacy. These converging factors contribute significantly to market expansion in animal nutrition applications worldwide.
In the pharmaceutical and nutraceutical sector, MOS is also increasingly used for its immunomodulatory and prebiotic properties. Advancements in extraction, purification, and standardization technologies allow manufacturers to produce high-purity MOS suitable for human health products, including digestive supplements and immune support formulations. Companies like Beneo, Ingredion, and Kemin Industries are also developing clinically validated MOS ingredients that meet regulatory standards, enhancing bioavailability and functional performance. This technological progress is also driving MOS adoption in dietary supplements and functional foods, expanding its market beyond animal feed into human health applications.
02

Restraint: High production costs and limited large‑scale raw material availability constrain market expansion

Mannan oligosaccharide production involves complex extraction and purification processes that require significant investment in technology and quality control. Limited availability of high‑grade yeast derivatives and related raw materials can drive up manufacturing costs, making MOS products more expensive than alternative prebiotics. For example, smaller feed producers may avoid MOS due to premium pricing, reducing overall demand and slowing revenue growth for suppliers focused on animal nutrition segments.
03

Opportunity: Antibiotic-free poultry and swine feeds using Mannan Oligosaccharide in Europe and Sustainable shrimp aquaculture feeds with MOS across Southeast Asia

Feed-grade Mannan Oligosaccharide offers compelling value as an Fanimal feed additive in antibiotic-free European poultry and swine production. Globally, the feed segment is forecast to rise from about $0.25 billion in 2024 to $0.45 billion by 2030, reflecting a robust 10.02% CAGR. Growth will be strongest in specialty premixes and starter feeds improving gut health, feed conversion, and pathogen control. Strategic collaborations between Mannan Oligosaccharide manufacturers, integrators, and veterinary nutritionists can unlock premium, performance-based formulations tailored to country-specific regulatory standards.
Aquaculture-focused MOS is underutilized in premium shrimp feeds across Southeast Asia, despite intense disease pressure and tightening residue regulations. Positioned as a sustainable ingredient that enhances immunity, microbiome modulation, and survival rates, MOS can help regional producers reduce antibiotic dependence while maintaining export-grade quality. Within the rapidly expanding feed-grade market, the fastest growth potential lies in vannamei shrimp and high-density pond systems, where specialized aquaculture feed formulations and long-term supply partnerships with mills and integrators can secure recurring, value-added demand.
04

Challenge: Lack of broad regulatory harmonization and clinical evidence restricts wider application adoption

The MOS market faces regulatory challenges because approval standards and health claim substantiation vary across regions and industries. In pharmaceutical and human nutraceutical applications, inconsistent regulatory frameworks and limited large‑scale clinical evidence can delay product launches and constrain marketing claims. As a result, some manufacturers hesitate to invest in expansion for human health applications, narrowing market opportunities and affecting long‑term demand outside traditional animal feed uses.

Supply Chain Landscape

1

Yeast Fermentation Inputs

Lallemand Inc.DuPont
2

Mannan Oligosaccharide Processing

Alltech Inc.Kemin Industries Inc
3

Prebiotic Feed Additives

Orffa International HoldingAlltech Inc
4

Animal Nutrition Applications

Poultry feedAquaculture feedAnimal nutrition
Mannan Oligosaccharide - Supply Chain

Use Cases of Mannan Oligosaccharide in Functional Feed Additives & Pharmaceutical Use

Functional Feed Additives : In the functional feed additives sector, mannan oligosaccharides derived from yeast cell walls are widely used to promote gut health, improve nutrient absorption and strengthen immune response in livestock and aquaculture. These prebiotic compounds help maintain beneficial gut microflora, reduce pathogen adhesion, and support overall animal performance. Leading suppliers such as Alltech, Cargill, and ADM provide high‑quality MOS products that are integrated into feed formulations, leveraging strong R&D, global distribution networks, and brand trust to support sustainable animal nutrition solutions.
Pharmaceutical Use : In pharmaceutical applications, purified MOS are utilized for their immunomodulatory and anti‑inflammatory properties to support human health supplements and therapeutic formulations. MOS serves as a prebiotic ingredient in digestive health products and is studied for its potential to enhance immune function. Key players like Beneo (a Südzucker Group company), Ingredion Incorporated, and Kemin Industries supply pharmaceutical‑grade MOS, emphasizing rigorous quality control, clinical validation, and regulatory compliance to meet stringent industry standards.
Wastewater Treatment : In wastewater treatment, MOS‑based bioflocculants and adsorbents are increasingly adopted to improve the removal of suspended solids, organic pollutants and heavy metals. MOS’s natural affinity for binding contaminants enhances floc formation and accelerates sedimentation, making treatment processes more efficient and eco‑friendly. Companies such as SNF Group, Anhui Seongon Chemical and Lodestar Industries leverage their expertise in polysaccharide chemistry and industrial scale production to deliver effective wastewater treatment additives for municipal and industrial applications.

Recent Developments

Recent developments in the mannan oligosaccharide market highlight growing adoption in animal nutrition, functional feed additives, and human dietary supplements. A key trend is the rising focus on gut health and immunity support, driving demand for high-purity, prebiotic MOS formulations. Manufacturers like Alltech, Cargill, and Beneo are leveraging advanced extraction and purification technologies to deliver consistent quality and enhanced bioactivity. The convergence of health-conscious feeding practices, sustainable animal production, and nutraceutical innovation is expanding MOS applications across multiple industries.

September 2024 : Lallemand Inc. announced the expansion of its MOS production facility in Milwaukee, Wisconsin, increasing annual capacity by 15,000 tons. The $28 million investment includes advanced purification technology to improve product consistency and lower production costs to meet rising North American demand.
July 2024 : Angel Yeast Co., Ltd. entered a collaboration with the Chinese Academy of Agricultural Sciences to co‑develop next‑generation MOS products with enhanced prebiotic activity and optimized molecular profiles for improved animal health performance.
June 2024 : Alltech Inc. introduced its MOS‑Plus product line, featuring proprietary encapsulation technology that protects active compounds during feed processing and storage, addressing key industry challenges in animal nutrition.

Impact of Industry Transitions on the Mannan Oligosaccharide Market

As a core segment of the Animal Feeds industry, the Mannan Oligosaccharide market develops in line with broader industry shifts. Over recent years, transitions such as Increasing Demand in Animal Feed Industry and Global Health and Wellness Trend have redefined priorities across the Animal Feeds sector, influencing how the Mannan Oligosaccharide market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Increasing Demand in Animal Feed Industry

The MOS market is at a pivotal inflection point as rising demand for gut-health-focused prebiotics in the animal feed industry collides with slow strategic adoption by key incumbents, opening a measurable revenue gap. While MOS is increasingly recognized for improving animal nutrition, livestock performance, and reducing antibiotic dependence, hesitancy among leading producers to fully scale and differentiate these functional feed additives is enabling Fructo oligosaccharides and Galacto oligosaccharides to accelerate use-case penetration. These alternative oligosaccharides are rapidly capturing applications in animal nutrition & feed and food & beverage processing, and are projected to divert approximately $110 million from the existing MOS market. This transition signals intensifying competitive pressure and underlines the urgency for MOS stakeholders to reinforce value propositions, optimize formulations, and expand integrated prebiotic solutions to defend share in high-growth animal health and nutrition segments.
02

Global Health and Wellness Trend

The MOS market is experiencing a notable transition driven by the global focus on health and wellness, particularly the rising consumer interest in dietary supplements and functional foods. MOS is increasingly incorporated in human nutraceuticals and digestive health products due to its prebiotic and immunomodulatory properties, supporting gut health and overall well-being. This trend is influencing associated industries, including pharmaceuticals, dietary supplements, and functional beverages, as companies like Beneo, Ingredion, and Kemin Industries develop clinically validated, high-purity MOS ingredients. The shift toward preventive healthcare and natural solutions is encouraging innovation in formulation, expanding applications beyond animal feed into human nutrition, while boosting demand for standardized, high-quality MOS products across global health-focused markets.